Mario Augusto Izidoro

Dr. Mario Augusto Izidoro

Laboratory of Mass Spectrometry, Hospital São Paulo, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
Mario Augusto IzidoroMario Augusto Izidoro
Mario Augusto Izidoro
IGIuri E. Gouvea
Iuri E. Gouvea
JSJorge A.N. Santos
Jorge A.N. Santos
DADiego M. Assis
Diego M. Assis
Vitor OliveiraVitor Oliveira
Vitor Oliveira
LJLuiz Juliano
Luiz Juliano

16 November 2006 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
IGI.E. Gouvea
I.E. Gouvea
Mario Augusto IzidoroMario Augusto Izidoro
Mario Augusto Izidoro
WJWagner Alves de Souza Judice
Wagner Alves de Souza Judice
MCM.H.S. Cezari
M.H.S. Cezari
Giuseppe CaliendoGiuseppe Caliendo
Giuseppe Caliendo
LJL. Juliano
L. Juliano

1 October 2015 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
LALetícia de Almeida
Letícia de Almeida
KAKarina Ferreira Alves
Karina Ferreira Alves
CMClaudia Mara Maciel-Rezende
Claudia Mara Maciel-Rezende
LJLarissa de Oliveira Passos Jesus
Larissa de Oliveira Passos Jesus
FPFrancieli Ribeiro Pires
Francieli Ribeiro Pires
MMMarcos José Marques
Marcos José Marques

23 December 2009 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
GTGustavo Trossini
Gustavo Trossini
AMAlberto Malvezzi
Alberto Malvezzi
AAAntonia Tavares Do Amaral
Antonia Tavares Do Amaral
CRCARLOTA RANGEL-YAGUI
CARLOTA RANGEL-YAGUI
Mario Augusto IzidoroMario Augusto Izidoro
Mario Augusto Izidoro
EFElizabeth Igne Ferreira
Elizabeth Igne Ferreira
Nitrofurazone (NF) and its derivative, hydroxymethylnitrofurazone (NFOH), have presented antichagasic activity. NFOH has higher activity and lower mutagenicity. The aim of this work was to assess whether NF and its derivative NFOH would also be inhibitors of cruzain, besides their trypanothione reductase inhibitory activity. In vitro cruzain inhibition tests were performed for both compounds, and the 50% inhibitory concentration (IC50) for NF and NFOH presented values of 22.83 ± 1.2 μM and 10.55 ± 0.81 μM, respectively. AM1 semi-empirical molecular modeling studies were performed to understand the activity of the compounds, corroborating the observed cruzain inhibitory activity.

2 April 2012 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
DADiego Magno Assis
Diego Magno Assis
VGVanessa Silva Gontijo
Vanessa Silva Gontijo
IPIvan de Oliveira Pereira
Ivan de Oliveira Pereira
JSJorge Alexandre Nogueira Santos
Jorge Alexandre Nogueira Santos
Ihosvany CampsIhosvany Camps
Ihosvany Camps
MJMaria Aparecida Juliano
Maria Aparecida Juliano
Cruzain is the major cysteine protease of Trypanosoma cruzi, the infectious agent responsible for Chagas disease, and cruzain inhibitors display considerable antitrypanosomal activity. In the present work we elucidated crystallographic data of fukugetin, a biflavone isolated from Garcinia brasiliensis, and investigated the role of this molecule as cysteine protease inhibitor. The kinetic analyses demonstrated that fukugetin inhibited cruzain and papain by a slow reversible type inhibition with KI of 1.1 and 13.4 µM, respectively. However, cruzain inhibition was about 12 times faster than papain inhibition. Lineweaver–Burk plots demonstrated partial competitive inhibition for cruzain and hyperbolic mixed-type inhibition for papain. Furthermore, the docking results showed that the biflavone binds to ring C′ in the S2 pocket and to ring C in the S3 pocket through hydrophobic interactions and hydrogen bonds. Finally, fukugetin also presented inhibitory activity on proteases of the T. cruzi extract, with IC50 of 7 µM.

1 December 2014 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
FMFernando Yukio Maeda
Fernando Yukio Maeda
CCCristian Cortez
Cristian Cortez
Mario Augusto IzidoroMario Augusto Izidoro
Mario Augusto Izidoro
LJLuiz Juliano
Luiz Juliano
NYNobuko Yoshida
Nobuko Yoshida
Trypanosoma cruzi, the agent of Chagas disease, binds to diverse extracellular matrix proteins. Such an ability prevails in the parasite forms that circulate in the bloodstream and contributes to host cell invasion. Whether this also applies to the insect-stage metacyclic trypomastigotes, the developmental forms that initiate infection in the mammalian host, is not clear. UsingT. cruziCL strain metacyclic forms, we investigated whether fibronectin bound to the parasites and affected target cell invasion. Fibronectin present in cell culture medium bound to metacyclic forms and was digested by cruzipain, the majorT. cruzicysteine proteinase. G strain, with negligible cruzipain activity, displayed a minimal fibronectin-degrading effect. Binding to fibronectin was mediated by gp82, the metacyclic stage-specific surface molecule implicated in parasite internalization. When exogenous fibronectin was present at concentrations higher than cruzipain can properly digest, or fibronectin expression was stimulated by treatment of epithelial HeLa cells with transforming growth factor beta, the parasite invasion was reduced. Treatment of HeLa cells with purified recombinant cruzipain increased parasite internalization, whereas the treatment of parasites with cysteine proteinase inhibitor had the opposite effect. Metacyclic trypomastigote entry into HeLa cells was not affected by anti-β1 integrin antibody but was inhibited by anti-fibronectin antibody. Overall, our results have indicated that the cysteine proteinase ofT. cruzimetacyclic forms, through its fibronectin-degrading activity, is implicated in host cell invasion.